Our Services
Medical Information
Helpful Resources
Published on: 3/7/2026
Myelodysplastic syndrome (MDS) is a bone marrow failure disorder that causes low red blood cells, white blood cells, and platelets. Common symptoms include persistent fatigue, shortness of breath, frequent infections, and easy bruising. Doctors confirm MDS through blood tests, a bone marrow biopsy, and genetic testing.
Medically approved treatments include supportive care such as blood transfusions and growth factors, disease-modifying medications like hypomethylating agents or lenalidomide for specific genetic profiles, and stem cell transplant for eligible patients. Seek urgent care immediately for chest pain, severe breathlessness, high fever, or uncontrolled bleeding.
Because MDS symptoms overlap with many other conditions—from anemia to leukemia—guessing can delay proper care. A free, AI-powered symptom check takes just 3 minutes, is backed by physicians, and gives you a personalized report of possible causes and recommended next steps you can share with your doctor. Take the guesswork out of your symptoms and get clarity now.
Reviewed for medical accuracy: 07/09/2026
Not seeing your question? No worries.
Submit your own QuestionIf you feel exhausted no matter how much you sleep, get winded walking up stairs, or notice frequent infections or easy bruising, your blood cells may not be working the way they should.
One possible cause is myelodysplastic syndrome (MDS) — a group of disorders where the bone marrow does not produce healthy blood cells effectively. MDS is sometimes called a "bone marrow failure disorder." It is most common in adults over 60, but it can occur at any age.
Let's break down what this means, how it affects your body, and what medically approved next steps look like.
Your bone marrow is the factory that makes:
In myelodysplastic syndrome, the bone marrow produces immature or defective cells that either don't work properly or die early. This leads to low blood counts, also known as cytopenias.
Over time, MDS can range from mild and slow-moving to more aggressive forms that may progress to acute myeloid leukemia (AML).
Fatigue is the most common symptom of myelodysplastic syndrome.
Here's why:
This can cause:
If persistent fatigue is affecting your daily life, it's important to determine whether low red blood cell counts could be the underlying cause. You can quickly check if your symptoms might be related to anemia using Ubie's free AI-powered symptom assessment tool, which takes just a few minutes and can help you understand whether it's time to speak with a healthcare provider.
Because MDS affects multiple blood cell types, symptoms vary depending on which cells are low:
Some people have mild symptoms at first. Others may not realize anything is wrong until routine blood work shows abnormalities.
In many cases, the exact cause is unknown. This is called primary MDS.
However, risk factors include:
MDS develops because of changes (mutations) in the DNA of bone marrow stem cells. These changes prevent normal blood development.
If blood tests show low counts, your doctor may recommend further evaluation.
Diagnosis typically includes:
A bone marrow biopsy can sound intimidating, but it is usually done under local anesthesia and takes about 20–30 minutes.
Accurate diagnosis is critical because treatment decisions depend on the specific type and risk category of myelodysplastic syndrome.
MDS is considered a type of cancer by many medical organizations because it involves abnormal, clonal growth of bone marrow cells.
However:
Doctors use scoring systems (such as IPSS-R or IPSS-M) to classify MDS as:
This classification guides treatment decisions.
Treatment depends on:
For lower-risk MDS, supportive care is often the first step:
Supportive care can significantly improve quality of life.
For certain types of myelodysplastic syndrome:
These medications can reduce transfusion needs and improve survival in appropriate patients.
This is currently the only potential cure for myelodysplastic syndrome.
However:
Transplant decisions require evaluation by a hematologist specializing in bone marrow disorders.
You should seek urgent medical care if you experience:
These can be serious complications of low blood counts.
Even if symptoms seem mild, persistent fatigue, unexplained bruising, or repeated infections are not normal. They deserve medical evaluation.
If you are diagnosed with MDS, remember:
You may need:
Lifestyle habits that support overall health include:
If you are "always tired," don't ignore it. While common causes like iron deficiency or stress are frequent, persistent fatigue may signal something deeper — including myelodysplastic syndrome.
MDS occurs when your bone marrow fails to produce healthy blood cells. It can cause:
The good news is that modern medicine offers:
Before your doctor's appointment, use Ubie's free AI-powered tool to assess your anemia symptoms in just a few minutes — it can help you understand if your exhaustion might be related to low red blood cell counts and prepare you with informed questions for your healthcare provider.
Most importantly, speak to a doctor promptly if you experience persistent fatigue, unexplained bruising, infections, chest pain, shortness of breath, or any symptom that could be serious or life-threatening. Early evaluation and proper diagnosis are the key to better outcomes.
Your body sends signals for a reason. Listening to them — and acting early — can make all the difference.
(References)
* Cortes-Hernandez J, Delgadillo-Rodríguez R, Flores-García A, Colunga-Pedraza PR, Moncada-Barrón A. Fatigue in Myelodysplastic Syndromes: Pathophysiology and Management. Front Oncol. 2021 Jul 21;11:665576. doi: 10.3389/fonc.2021.665576. PMID: 34368149; PMCID: PMC8334460.
* Sekeres MA, et al. Myelodysplastic syndromes: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023 Jan;98(1):198-223. doi: 10.1002/ajh.26786. PMID: 36520779.
* Zhu B, Lin Y. Current and emerging therapies for myelodysplastic syndromes (MDS). Exp Hematol Oncol. 2023 Oct 26;12(1):101. doi: 10.1186/s40164-023-00465-9. PMID: 37880790; PMCID: PMC10599572.
* Papaemmanuil E, Tavakkoli M, Mistry N. The molecular pathology of myelodysplastic syndromes. Blood. 2022 Aug 4;140(5):441-453. doi: 10.1182/blood.2021014902. PMID: 35926102.
* Brugnaro D, et al. Patient-Reported Outcomes in Myelodysplastic Syndromes. Cancers (Basel). 2022 Feb 22;14(5):1134. doi: 10.3390/cancers14051134. PMID: 35267434; PMCID: PMC8909893.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.